When cancer treatment is discussed in Bangladesh, the focus usually falls on advanced technologies—linear accelerators, PET-CT scanners, MRI machines, robotic surgery, and the latest cancer drugs. While these innovations are undeniably important, they tell only part of the story.
The more fundamental question is: Who will operate these technologies?
A state-of-the-art radiotherapy machine can be purchased with sufficient funding. However, developing a skilled radiation oncologist, medical physicist, radiotherapy technologist, or oncology nurse requires years of education, clinical training, and continuous professional development. In other words, buying equipment is relatively straightforward; building a highly qualified workforce is far more challenging.
For this reason, one of the most pressing issues in global cancer care today is the oncology workforce—the availability of trained healthcare professionals capable of delivering high-quality cancer treatment.
Cancer Care Is a Team Effort
Cancer treatment is never the responsibility of a single physician. Effective care depends on a multidisciplinary team that includes:
Surgical oncologists
Medical oncologists
Radiation oncologists
Pathologists
Radiologists
Medical physicists
Oncology nurses
Radiotherapy technologists
Nutritionists
Psychologists
Palliative care specialists
The absence of even one member of this team can compromise the quality of treatment. Cancer care is therefore not an individual effort but a coordinated, team-based service.
Bangladesh’s Progress—and Its Challenge
Bangladesh has made significant progress in expanding cancer care infrastructure. Modern cancer centers have been established in both the public and private sectors, and access to advanced radiotherapy, chemotherapy, targeted therapy, and immunotherapy has improved.
However, an important question remains:
Has the country’s skilled oncology workforce grown at the same pace?
The reality is that many hospitals continue to face serious shortages. In some facilities, a single oncologist is responsible for an overwhelming number of patients. Others lack sufficient medical physicists, trained oncology nurses, or radiotherapy technologists.
As a result, even when advanced equipment is available, its full potential cannot be utilized.
The Cost of Workforce Shortages
Ultimately, patients bear the greatest burden.
Insufficient staffing leads to delayed diagnoses, longer waiting times, postponed treatment, and increased pressure on healthcare professionals. In cancer care, time is critical. Even a delay of a few weeks can reduce treatment options and negatively affect patient outcomes.
Workforce shortages are therefore not merely administrative issues—they can directly influence survival and quality of life.
What the World Is Doing
International organizations such as the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), and leading oncology societies now recognize workforce development as a central pillar of cancer control.
Countries including Australia, the United Kingdom, Canada, and Singapore routinely forecast how many oncologists, oncology nurses, medical physicists, and technologists they will require over the next 10 to 20 years. They align education, training, recruitment, and infrastructure development with these long-term projections.
In other words, they invest not only in hospitals but also in the professionals needed to operate them effectively.
What Bangladesh Needs
Bangladesh would benefit from a comprehensive national oncology workforce strategy.
Such a plan should estimate the country’s future need for specialist physicians, oncology nurses, medical physicists, and radiotherapy technologists over the next two decades. Training capacity should then be expanded accordingly, while cancer services are strengthened beyond major urban centers.
At the same time, retaining skilled professionals requires supportive working conditions, opportunities for career development, and continued investment in research and education.
Can Artificial Intelligence Solve the Problem?
Artificial intelligence (AI) is already transforming cancer care by assisting with diagnosis, radiotherapy planning, medical imaging, and patient management.
However, AI is not a substitute for healthcare professionals.
Its greatest value lies in supporting skilled clinicians—not replacing them. Without a well-trained workforce, even the most sophisticated AI systems cannot deliver meaningful improvements in patient care.
Investment, Not Expenditure
Healthcare spending is often viewed as a cost. In reality, investing in oncology professionals is an investment in national development.
A stronger workforce enables earlier diagnosis, timely treatment, fewer complications, lower healthcare costs, greater workforce productivity, and reduced dependence on overseas medical care.
The benefits extend well beyond the healthcare sector and contribute to broader economic and social development.
The Way Forward
Bangladesh has made encouraging progress in cancer treatment, but greater challenges lie ahead. As cancer cases continue to rise and treatment becomes increasingly complex, investment in technology alone will not be sufficient.
The country needs a realistic, long-term strategy that gives equal priority to infrastructure, technology, and—most importantly—people.
Modern hospitals are built with buildings and equipment. Modern cancer care systems are built with skilled professionals.
The greatest investment in the fight against cancer is not in machines—it is in people.
